专利信息

首页 1 2 3 4 5 6 下页尾页共 382 条记录, 当前第1/39页。

专利标题：Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350

专利权人：MEDIVIR AB;

Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1 :100 to 1 :350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine...

专利标题：Method for preparing zidovudine and intermediate thereof

专利标题：Compound anti-aids pharmaceutic preparation

专利标题：Compound anti-aids (acquired immune deficiency syndrome) medicine orally taken suspension preparation

专利标题：Method for synthesizing nucleotide phosphoramidate and nucleotide thio-phosphoramidate

专利标题：Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350

专利权人：MEDIVIR AB;

Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1:100 to 1:350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine a...

专利标题：COMBINATION OF ALOVUDINE AND ZIDOVUDINE IN A MOLAR RATIO OF 1:100 TO 1:350

专利权人：MEDIVIR AB [US];MEDIVIR AB [SE];

Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1:100 to 1:350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine a...

专利标题：One group of tynofovir ester cpds, preparation method and in the application of anti-virus aspect

专利权人：Luoyang Juhui Investment Inc.;

专利标题：One group of tynofovir ester cpds, preparation method and in the application of anti-virus aspect

专利权人：Luoyang Juhui Investment Inc.;

当前查询条件: [药品] 包含 'Zidovudine'

	查询范围	在当前结果中查询
!	专利类型	发明实用新型外观设计
!	公开号			CN1234
!	申请号			CN1234
!	专利标题		扩展	PHARMA
!	专利权人		扩展	pfizer
	发明人
!	申请日			yyyymmdd
!	公开日			yyyymmdd
	优先权号
!	摘要		扩展	PHARMA
	IPC			A01B

1. CA2651232C	2013/12/31	CA20072651232	2007/5/4
专利标题：Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 专利权人：MEDIVIR AB; Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1 :100 to 1 :350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine...

2. CN103443095A	2013/12/11	CN2011802522	2011/11/7
专利标题：Method for preparing zidovudine and intermediate thereof 专利权人：Shanghai Desano Pharmaceuticals Invest Co Ltd;

3. CN103443115A	2013/12/11	CN2011802520	2011/11/7
专利标题：Method for preparing zidovudine and intermediate thereof 专利权人：Shanghai Desano Pharmaceuticals Investment Co., Ltd.;

4. CN103417564A	2013/12/4	CN2013141864	2013/2/1
专利标题：Compound anti-aids pharmaceutic preparation 专利权人：University Of Shanghai For Science & Technology;

5. CN103405440A	2013/11/27	CN20131277182	2013/7/3
专利标题：Compound anti-aids (acquired immune deficiency syndrome) medicine orally taken suspension preparation 专利权人：Shanghai Meiyou Pharmaceutical Co., Ltd.;

6. CN103408624A	2013/11/27	CN20131282582	2013/7/8
专利标题：Method for synthesizing nucleotide phosphoramidate and nucleotide thio-phosphoramidate 专利权人：Jiangxi Science & Technology Normal University;

7. US20130217646A1	2013/8/22	US13/757732	2013/2/1
专利标题：Combination of alovudine and zidovudine in a molar ratio of 1:100 to 1:350 专利权人：MEDIVIR AB; Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1:100 to 1:350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine a...

8. US2013217646A1	2013/8/22	US201313757732	2013/2/1
专利标题：COMBINATION OF ALOVUDINE AND ZIDOVUDINE IN A MOLAR RATIO OF 1:100 TO 1:350 专利权人：MEDIVIR AB [US];MEDIVIR AB [SE]; Co-administration of alovudine and zidovudine at ratios considerably in excess of the prior art completely or substantially abolishes the mitochondrial toxicity of alovudine in mitochondrial DNA depletion experiments. The invention thus provides pharmaceutical compositions comprising alovudine and zidovudine in a molar ratio in the range 1:100 to 1:350 and methods for the treatment or prophylaxis of multiply resistant HIV comprising the simultaneous or consequential administration of alovudine a...

9. CN103242366A	2013/8/14	CN20131134491	2013/4/17
专利标题：One group of tynofovir ester cpds, preparation method and in the application of anti-virus aspect 专利权人：Luoyang Juhui Investment Inc.;

10. CN103224530A	2013/7/31	CN20131134160	2013/4/17
专利标题：One group of tynofovir ester cpds, preparation method and in the application of anti-virus aspect 专利权人：Luoyang Juhui Investment Inc.;

下载范围

下载内容